{"id":"https://openalex.org/W4384698784","doi":"https://doi.org/10.2174/2211352521666230717115823","title":"Novel and Predictive QSAR Model and Molecular Docking: New Natural Sulfonamides of Potential Concern against SARS-Cov-2","display_name":"Novel and Predictive QSAR Model and Molecular Docking: New Natural Sulfonamides of Potential Concern against SARS-Cov-2","publication_year":2023,"publication_date":"2023-07-18","ids":{"openalex":"https://openalex.org/W4384698784","doi":"https://doi.org/10.2174/2211352521666230717115823"},"language":"en","primary_location":{"id":"doi:10.2174/2211352521666230717115823","doi":"https://doi.org/10.2174/2211352521666230717115823","is_oa":false,"landing_page_url":"https://doi.org/10.2174/2211352521666230717115823","pdf_url":null,"source":{"id":"https://openalex.org/S4210177725","display_name":"Anti-Infective Agents","issn_l":"1568-0126","issn":["1568-0126","1871-5214","1875-600X","1875-6018","2211-3525","2211-3533"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Infective Agents","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036059716","display_name":"Nathalie Moussa","orcid":"https://orcid.org/0000-0002-0970-1060","observed_orcids":["https://orcid.org/0000-0002-0970-1060"]},"institutions":[{"id":"https://openalex.org/I4387154185","display_name":"Manara University","ror":"https://ror.org/058cmte92","country_code":"SY","type":"education","lineage":["https://openalex.org/I4387154185"]}],"countries":["SY"],"is_corresponding":true,"raw_author_name":"Nathalie Moussa","raw_affiliation_strings":["Department of Pharmaceutical Chemistry and Drug Control, Manara University, Latakia, Syria"],"raw_orcid":"https://orcid.org/0000-0002-0970-1060","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry and Drug Control, Manara University, Latakia, Syria","institution_ids":["https://openalex.org/I4387154185"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077217160","display_name":"Huda Mando","orcid":"https://orcid.org/0000-0001-7447-8507","observed_orcids":["https://orcid.org/0000-0001-7447-8507"]},"institutions":[{"id":"https://openalex.org/I2801484940","display_name":"Arab International University","ror":"https://ror.org/05skgxb48","country_code":"SY","type":"education","lineage":["https://openalex.org/I2801484940"]}],"countries":["SY"],"is_corresponding":false,"raw_author_name":"Huda Mando","raw_affiliation_strings":["Faculty of Pharmacy,\nDepartment of Pharmaceutical Chemistry and Quality Control of Medicaments, Arab International University, Damascus,\nSyria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy,\nDepartment of Pharmaceutical Chemistry and Quality Control of Medicaments, Arab International University, Damascus,\nSyria","institution_ids":["https://openalex.org/I2801484940"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5036059716"],"corresponding_institution_ids":["https://openalex.org/I4387154185"],"apc_list":null,"apc_paid":null,"fwci":0.174,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.33706887,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"21","issue":"5","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9850000143051147},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9129999876022339},{"id":"https://openalex.org/keywords/cyclic-sulfonamides","display_name":"cyclic sulfonamides","score":0.8669999837875366},{"id":"https://openalex.org/keywords/sulfamates","display_name":"sulfamates","score":0.8399999737739563},{"id":"https://openalex.org/keywords/natural-products","display_name":"natural products","score":0.6930000185966492},{"id":"https://openalex.org/keywords/antiviral-activity-prediction","display_name":"antiviral activity prediction","score":0.6669999957084656},{"id":"https://openalex.org/keywords/qsar-modeling","display_name":"QSAR models","score":0.9259999990463257},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7919999957084656},{"id":"https://openalex.org/keywords/multiple-linear-regression","display_name":"multiple linear regression","score":0.6769999861717224},{"id":"https://openalex.org/keywords/molecular-descriptors","display_name":"molecular descriptors","score":0.6809999942779541},{"id":"https://openalex.org/keywords/virtual-screening","display_name":"virtual screening","score":0.5559999942779541},{"id":"https://openalex.org/keywords/drug-design","display_name":"drug design","score":0.7879999876022339}],"concepts":[{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.843671977519989},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.5953797698020935},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.4852583110332489},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.4631385803222656},{"id":"https://openalex.org/C103697762","wikidata":"https://www.wikidata.org/wiki/Q4112105","display_name":"Virtual screening","level":3,"score":0.4595341682434082},{"id":"https://openalex.org/C48921125","wikidata":"https://www.wikidata.org/wiki/Q10861030","display_name":"Linear regression","level":2,"score":0.4310155510902405},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4183278977870941},{"id":"https://openalex.org/C63479239","wikidata":"https://www.wikidata.org/wiki/Q7353546","display_name":"Robustness (evolution)","level":3,"score":0.41404855251312256},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35066673159599304},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33312007784843445},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.27709323167800903},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.25450047850608826},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2385505735874176},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.23414626717567444},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23407581448554993},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22133752703666687},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.21537750959396362},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.19971218705177307},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12619492411613464},{"id":"https://openalex.org/C42972112","wikidata":"https://www.wikidata.org/wiki/Q170201","display_name":"Veterinary medicine","level":1,"score":0.10012432932853699},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.06721615791320801},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/2211352521666230717115823","doi":"https://doi.org/10.2174/2211352521666230717115823","is_oa":false,"landing_page_url":"https://doi.org/10.2174/2211352521666230717115823","pdf_url":null,"source":{"id":"https://openalex.org/S4210177725","display_name":"Anti-Infective Agents","issn_l":"1568-0126","issn":["1568-0126","1871-5214","1875-600X","1875-6018","2211-3525","2211-3533"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Infective Agents","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W2011580004","https://openalex.org/W2058220696","https://openalex.org/W2074681440","https://openalex.org/W2087661061","https://openalex.org/W2088321706","https://openalex.org/W2100349128","https://openalex.org/W2143088831","https://openalex.org/W2176009755","https://openalex.org/W2414870557","https://openalex.org/W3012567113","https://openalex.org/W3029223018","https://openalex.org/W3035461809","https://openalex.org/W3097499475","https://openalex.org/W3137233710","https://openalex.org/W3147903376","https://openalex.org/W3159177617","https://openalex.org/W3184592174","https://openalex.org/W3199598568","https://openalex.org/W3207991896","https://openalex.org/W3216428025","https://openalex.org/W4200233474"],"related_works":["https://openalex.org/W3202446236","https://openalex.org/W3085805037","https://openalex.org/W3152239024","https://openalex.org/W4390775876","https://openalex.org/W4315477074","https://openalex.org/W3086832859","https://openalex.org/W7149419019","https://openalex.org/W4285506727","https://openalex.org/W4387491137","https://openalex.org/W4318609739"],"abstract_inverted_index":{"Background:":[0],"Since":[1],"the":[2,5,10,36,62,73,97,103,111,115,123,154,160,164,169,198,204,210,221,232,235],"outbreak":[3],"of":[4,38,64,75,125,195,212,234],"COVID-19":[6],"pandemic":[7],"in":[8,101,122],"2019,":[9],"world":[11],"has":[12],"been":[13],"racing":[14],"to":[15,51,71,137,229],"develop":[16],"effective":[17,129],"drugs":[18,40],"for":[19,113,197,203,254,269],"treating":[20],"this":[21,58],"deadly":[22],"disease.":[23],"Although":[24],"there":[25,46],"are":[26],"now":[27],"some":[28],"vac-cines":[29],"that":[30,153,249],"have":[31],"somewhat":[32],"alleviated":[33],"global":[34],"panic,":[35],"lack":[37],"approved":[39],"remains":[41],"a":[42,48,65,190,243],"persistent":[43],"challenge.":[44],"Consequently,":[45],"is":[47],"pressing":[49],"need":[50],"discover":[52],"new":[53,126],"therapeutic":[54],"molecules.":[55],"Methods:":[56],"In":[57],"study,":[59],"we":[60,208],"explore":[61],"application":[63],"quantitative":[66],"structure\u2212activity":[67],"relationship":[68],"(QSAR)":[69],"model":[70,83,109,133,176],"predict":[72],"efficacy":[74],"28":[76],"cyclic":[77],"sulfonamide":[78],"derivatives":[79],"against":[80,172,246,267],"SARS-CoV-2.":[81,173],"The":[82,132,149,174],"was":[84,134,177,227],"developed":[85],"using":[86,179],"multiple":[87],"linear":[88],"regression,":[89],"and":[90,118,127,143,187,201,216,231,257,275],"six":[91],"molecular":[92],"descriptors":[93],"were":[94],"identified":[95],"as":[96,157,242],"most":[98,165],"significant":[99,166],"factors":[100],"determining":[102],"inhibitory":[104,170,265],"activity.":[105,224],"This":[106],"proposed":[107,175],"QSAR":[108],"holds":[110],"potential":[112,241],"aiding":[114],"virtual":[116],"screening":[117],"drug":[119],"design":[120],"process":[121],"development":[124],"more":[128],"SARS-CoV-2":[130,230,268],"inhibitors.":[131],"also":[135],"applied":[136],"seven":[138,213,270],"natural":[139,214,271],"products":[140],"primary":[141,273,276],"sulfonamides":[142],"sulfamates,":[144],"demonstrating":[145],"promising":[146,244,263],"activity":[147,171,211,266],"Results:":[148],"study":[150,237],"results":[151,233],"indicated":[152],"atom":[155],"count,":[156],"represented":[158],"by":[159],"descriptor":[161],"nCl,":[162],"had":[163],"impact":[167],"on":[168],"val-idated":[178],"various":[180],"statistical":[181],"parameters,":[182],"confirming":[183],"its":[184,240],"validity,":[185],"robustness,":[186],"predictiveness,":[188],"with":[189],"high":[191],"correlation":[192],"coefficient":[193],"(R2)":[194],"0.77":[196],"training":[199],"group":[200],"0.95":[202],"test":[205],"group.":[206],"Further-more,":[207],"predicted":[209,223,264],"compounds,":[215],"among":[217],"them,":[218],"Dealanylascamycin":[219,226],"exhibited":[220],"highest":[222],"Subsequently,":[225],"docked":[228],"docking":[236],"further":[238,255],"strengthened":[239],"candidate":[245],"COVID-19,":[247],"suggesting":[248],"it":[250],"should":[251],"be":[252],"considered":[253],"optimization":[256],"validation.":[258],"Conclusion:":[259],"Our":[260],"findings":[261],"demonstrate":[262],"products,":[272],"sulfonamides,":[274],"sulfamates.":[277]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-07-20T00:00:00"}